<DOC>
	<DOCNO>NCT00006050</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Giving drug different way may kill tumor cell . PURPOSE : Phase II trial study effectiveness liver perfusion use oxaliplatin plus leucovorin fluorouracil give infusion treat patient colorectal cancer spread liver .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Colorectal Cancer That Has Spread Liver</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy tolerance oxaliplatin hepatic perfusion combine intravenous leucovorin calcium fluorouracil patient liver metastasis colorectal cancer . OUTLINE : Patients receive oxaliplatin hepatic perfusion 2 hour day 1 plus leucovorin calcium IV 2 hour fluorouracil IV 22 hour day 1 2 . Treatment repeat every 14 day absence disease progression unacceptable toxicity . If good response achieve 8 course chemotherapy , patient may undergo surgical resection metastasis . PROJECTED ACCRUAL : A total 20-40 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven colorectal cancer metastatic liver Unresectable disease Less 50 % invasion liver Measurable disease No prior irradiation Largest diameter least 20 mm No detectable extrahepatic disease PATIENT CHARACTERISTICS : Age : Under 75 Performance status : WHO 02 Life expectancy : Greater 2 month Hematopoietic : WBC least 4,000/mm3 Neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 35 micromoles/L Renal : Creatinine le 130 micromoles/L Cardiovascular : No severe cardiac insufficiency Pulmonary : No respiratory disease would preclude study Other : No serious illness would preclude study No psychological illness would preclude study No peripheral neuropathy No prior malignancy consider cure Not pregnant Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior intravenous oxaliplatin No 1 prior regimen intravenous chemotherapy metastatic disease Primary chemotherapy fluorouracil allow stable progressive disease No concurrent chemotherapy Endocrine therapy : No concurrent hormonal therapy Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>liver metastasis</keyword>
</DOC>